A Comprehensive Peer Mentor-based Disease Management Program for Medically Complex Substance Users
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Substance-using adults are admitted to hospital for medical complication from their drug and alcohol use at very high rates; yet, their care is often defined by low rates of referral to addiction treatment programs and recidivism. In 1997, we instituted an integrated medical-substance use treatment program at Johns Hopkins, the First Step Day Hospital, designed for intensive post-acute care of previously hospitalized substance using adults. We have shown that patients with dual diagnoses admitted to First Step more often complete their course of medical care and stay in recovery longer than patients not admitted to First Step.(1;2) On discharge from First Step, patients are medically stable and drug-free. Their substance abuse care is transferred to an out-patient substance abuse treatment facility and their medical care is transferred to their primary care provider. Unfortunately, many patients are lost to follow-up during this transition. We believe that a peer mentor-based disease management program (PM) can provide continuity of care that begins in First Step and continues after discharge thereby increasing the proportion of patients who remain in treatment for their addiction and medical conditions. Peer mentors are persons from the target community who have been in recovery for 5 or more years. In cooperation with patients and providers, peer mentors improve the integration of care, quality of care, and access to healthcare services. This pilot study will test the effectiveness of a peer mentor-based disease management program. The specific aims are to compare the impact of the PM intervention verses enhanced usual care on outcomes in three domains (1) medical/psychiatric health status, (2) addiction recovery, and (3) social resource acquisition. If successful, this study will provide evidence supporting a larger randomized controlled trial of the impact of field workers on post-acute care among patients with dual diagnoses.
| Condition | Intervention |
|---|---|
|
Substance Addiction |
Behavioral: peer mentor-based disease management |
| Study Type: | Interventional |
| Study Design: | Allocation: Non-Randomized Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Supportive Care |
| Official Title: | A Comprehensive Peer Mentor-based Disease Management Program for Medically Complex Substance Users |
- adherence to first prescription refill after discharge [ Time Frame: 60 days ] [ Designated as safety issue: No ]
- Adherence to first medical appointment [ Time Frame: 60 days ] [ Designated as safety issue: No ]
- Rate of readmission and emergency department visits [ Time Frame: 3 years ] [ Designated as safety issue: No ]
- Length of stay in a recovery program [ Time Frame: 1 year ] [ Designated as safety issue: No ]
- Number of days without substance use [ Time Frame: 3 years ] [ Designated as safety issue: No ]
- Acquisition of medical insurance [ Time Frame: 1 year ] [ Designated as safety issue: No ]
- acquisition of long-term housing [ Time Frame: 3 years ] [ Designated as safety issue: No ]
- Acquisition of financial support [ Time Frame: 3 years ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 160 |
| Study Start Date: | January 2010 |
| Estimated Study Completion Date: | December 2013 |
| Estimated Primary Completion Date: | December 2013 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: Peer Mentor Intervention
peer mentor-based disease management focusing on three domains: medical care, recovery, and social stabilization
|
Behavioral: peer mentor-based disease management
peer mentor-based disease management focused on three domains: medical care, recovery, and social stabilization
|
Eligibility| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- All patients admitted to an intensive day hospital focused on medically complex substanse users are eligible for enrolment
Exclusion Criteria:
- Inability to provide informed consent
Contacts and Locations| Contact: Noreen Krause, BS | 4109553753 | nkrause1@jhmi.edu |
| United States, Maryland | |
| Johns Hopkins Hospital | Not yet recruiting |
| Baltmore, Maryland, United States, 21287 | |
| Contact: J H Young, MD, MHS 410-502-5808 jhyoung@jhmi.edu | |
| Sub-Investigator: Anika H. Alvanzo, MD, MS | |
More Information
No publications provided
| Responsible Party: | Jeffery Hunter Young, Assistant Professor, Johns Hopkins University |
| ClinicalTrials.gov Identifier: | NCT00993395 History of Changes |
| Other Study ID Numbers: | NA_00020931 |
| Study First Received: | October 9, 2009 |
| Last Updated: | October 9, 2009 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by Johns Hopkins University:
|
addiction peer mentor adherence |
Additional relevant MeSH terms:
|
Substance-Related Disorders Behavior, Addictive Mental Disorders Compulsive Behavior Impulsive Behavior |
ClinicalTrials.gov processed this record on June 18, 2013